1 – 10 of 172
      - show: 10
 - |
 - sort: year (new to old)
 
        Close
        
            
    
    Embed this list
<iframe src=""
              width=""
              height=""
              allowtransparency="true"
              frameborder="0">
            </iframe>
        - 2025
 - 
                        Mark
        Aneuploidy in neoplasia : Single-cell data on 83,862 tumors
    
    
- Contribution to journal › Article
 
 - 
                        Mark
        Distinct Signatures of Chromosomal Involvement in 59 251 Translocations Across 58 Tumor Types. A Novel Perspective
    
    
- Contribution to journal › Article
 
 - 2024
 - 
                        Mark
        Gene amplification in neoplasia : A cytogenetic survey of 80 131 cases
    
    
- Contribution to journal › Article
 
 - 2023
 - 
                        Mark
        Giemsa-negative chromosome bands preferentially recombine in cancer-associated translocations and gene fusions
    
    
- Contribution to journal › Article
 
 - 
                        Mark
        Transcriptomic subtyping of malignant peripheral nerve sheath tumours highlights immune signatures, genomic profiles, patient survival and therapeutic targets
    
    
- Contribution to journal › Article
 
 - 2020
 - 
                        Mark
        Genomic and transcriptomic features of dermatofibrosarcoma protuberans : Unusual chromosomal origin of the COL1A1-PDGFB fusion gene and synergistic effects of amplified regions in tumor development
    
    
- Contribution to journal › Article
 
 - 2019
 - 
                        Mark
        Most gene fusions in cancer are stochastic events
    
    
- Contribution to journal › Article
 
 - 
                        Mark
        Cancer chromosome breakpoints cluster in gene-rich genomic regions
    
    
- Contribution to journal › Article
 
 - 2018
 - 
                        Mark
        Different patterns of clonal evolution among different sarcoma subtypes followed for up to 25 years
    
    
- Contribution to journal › Article
 
 - 
                        Mark
        Inferior survival for patients with malignant peripheral nerve sheath tumors defined by aberrant TP53
    
    
- Contribution to journal › Article
 
 
